Life Science Investing Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
Life Science Investing Charles River Laboratories to Present at Jefferies Global Healthcare Conference
Life Science Investing Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development
Life Science Investing Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities
Life Science Investing Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption
Life Science Investing Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call
Life Science Investing Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing
Life Science Investing Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer
Life Science Investing Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences
Life Science Investing Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing
CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
